<page><tag>3</tag><title>Nektar Shares Continues Rise on Upgrades</title><text>Shares of Nektar Therapeutics remained active Wednesday following upgrades from two investment firms after drug giant Pfizer Inc. cited its inhalable insulin product in a recent pipeline report.</text></page>